These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27397848)

  • 1. Rapsyn congenital myasthenic syndrome worsened by fluoxetine.
    Visser AC; Laughlin RS; Litchy WJ; Benarroch EE; Milone M
    Muscle Nerve; 2017 Jan; 55(1):131-135. PubMed ID: 27397848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DOK7 myasthenic syndrome with subacute adult onset during pregnancy and partial response to fluoxetine.
    Santos M; Cruz S; Peres J; Santos L; Tavares P; Basto JP; Salgado V; Valverde AH
    Neuromuscul Disord; 2018 Mar; 28(3):278-282. PubMed ID: 29395672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrement with high frequency repetitive nerve stimulation in a RAPSN congenital myasthenic syndrome.
    LoRusso SJ; Iyadurai SJ
    Muscle Nerve; 2018 Mar; 57(3):E106-E108. PubMed ID: 29053879
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapsyn N88K is a frequent cause of congenital myasthenic syndromes in European patients.
    Müller JS; Mildner G; Müller-Felber W; Schara U; Krampfl K; Petersen B; Petrova S; Stucka R; Mortier W; Bufler J; Kurlemann G; Huebner A; Merlini L; Lochmüller H; Abicht A
    Neurology; 2003 Jun; 60(11):1805-10. PubMed ID: 12796535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up in patients with congenital myasthenic syndrome due to RAPSN mutations.
    Natera-de Benito D; Bestué M; Vilchez JJ; Evangelista T; Töpf A; García-Ribes A; Trujillo-Tiebas MJ; García-Hoyos M; Ortez C; Camacho A; Jiménez E; Dusl M; Abicht A; Lochmüller H; Colomer J; Nascimento A
    Neuromuscul Disord; 2016 Feb; 26(2):153-9. PubMed ID: 26782015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological and morphological characterization of a case of autosomal recessive congenital myasthenic syndrome with acetylcholine receptor deficiency due to a N88K rapsyn homozygous mutation.
    Yasaki E; Prioleau C; Barbier J; Richard P; Andreux F; Leroy JP; Dartevelle P; Koenig J; Molgó J; Fardeau M; Eymard B; Hantaï D
    Neuromuscul Disord; 2004 Jan; 14(1):24-32. PubMed ID: 14659409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical variability of early-onset congenital myasthenic syndrome due to biallelic RAPSN mutations in Brazil.
    Estephan EP; Zambon AA; Marchiori PE; da Silva AMS; Caldas VM; Moreno CAM; Reed UC; Horvath R; Töpf A; Lochmüller H; Zanoteli E
    Neuromuscul Disord; 2018 Nov; 28(11):961-964. PubMed ID: 30266223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired receptor clustering in congenital myasthenic syndrome with novel RAPSN mutations.
    Müller JS; Baumeister SK; Rasic VM; Krause S; Todorovic S; Kugler K; Müller-Felber W; Abicht A; Lochmüller H
    Neurology; 2006 Oct; 67(7):1159-64. PubMed ID: 16931511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique presentation of rapidly fluctuating symptoms in a child with congenital myasthenic syndrome due to RAPSN mutation.
    Kumar A; Asghar S; Kavanagh R; Wicklund MP
    Muscle Nerve; 2018 Oct; 58(4):E23-E24. PubMed ID: 30028532
    [No Abstract]   [Full Text] [Related]  

  • 10. Congenital myasthenic syndrome due to rapsyn deficiency: three cases with arthrogryposis and bulbar symptoms.
    Ioos C; Barois A; Richard P; Eymard B; Hantaï D; Estournet-Mathiaud B
    Neuropediatrics; 2004 Aug; 35(4):246-9. PubMed ID: 15328566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of next-generation sequencing as a diagnostic tool for congenital myasthenic syndrome.
    Das AS; Agamanolis DP; Cohen BH
    Pediatr Neurol; 2014 Nov; 51(5):717-20. PubMed ID: 25194721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A newly identified chromosomal microdeletion of the rapsyn gene causes a congenital myasthenic syndrome.
    Müller JS; Abicht A; Christen HJ; Stucka R; Schara U; Mortier W; Huebner A; Lochmüller H
    Neuromuscul Disord; 2004 Nov; 14(11):744-9. PubMed ID: 15482960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapsyn mutations in myasthenic syndrome due to impaired receptor clustering.
    Maselli RA; Dunne V; Pascual-Pascual SI; Bowe C; Agius M; Frank R; Wollmann RL
    Muscle Nerve; 2003 Sep; 28(3):293-301. PubMed ID: 12929188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in the TPR6 domain of the RAPSN gene associated with congenital myasthenic syndrome.
    Leshinsky-Silver E; Shapira D; Yosovitz K; Ginsberg M; Lerman-Sagie T; Lev D
    J Neurol Sci; 2012 May; 316(1-2):112-5. PubMed ID: 22326364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rare mutation in the COLQ gene causing congenital myasthenic syndrome with remarkable improvement to fluoxetine: A case report.
    Vidanagamage A; Gooneratne IK; Nandasiri S; Gunaratne K; Fernando A; Maxwell S; Cossins J; Beeson D; Chang T
    Neuromuscul Disord; 2021 Mar; 31(3):246-248. PubMed ID: 33487521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic yield of a practical electrodiagnostic protocol discriminating between different congenital myasthenic syndromes.
    Stojkovic T; Masingue M; Turmel H; Hezode-Arzel M; Béhin A; Leonard-Louis S; Bassez G; Bauché S; Blondy P; Richard P; Sternberg D; Eymard B; Fournier E; Villar-Quiles RN
    Neuromuscul Disord; 2022 Dec; 32(11-12):870-878. PubMed ID: 36522822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiexon deletions account for 15% of congenital myasthenic syndromes with RAPSN mutations after negative DNA sequencing.
    Gaudon K; Pénisson-Besnier I; Chabrol B; Bouhour F; Demay L; Ben Ammar A; Bauché S; Vial C; Nicolas G; Eymard B; Hantaï D; Richard P
    J Med Genet; 2010 Dec; 47(12):795-6. PubMed ID: 20930056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine.
    Dejthevaporn C; Wetchaphanphesat S; Pulkes T; Rattanasiri S; Engel AG; Witoonpanich R
    J Clin Neurosci; 2022 Feb; 96():85-89. PubMed ID: 34999496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of pathogenic mutations in the human rapsyn gene.
    Dunne V; Maselli RA
    J Hum Genet; 2003; 48(4):204-7. PubMed ID: 12730725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
    Banwell BL; Ohno K; Sieb JP; Engel AG
    Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.